- Home
- QURE vs BGSI Comparison
QURE vs BGSI Comparison
Compare QURE & BGSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QURE
- BGSI
- Stock Information
- Founded
- QURE 1998
- BGSI 1990
- Country
- QURE Netherlands
- BGSI Canada
- Employees
- QURE N/A
- BGSI N/A
- Industry
- QURE Biotechnology: Pharmaceutical Preparations
- BGSI
- Sector
- QURE Health Care
- BGSI
- Exchange
- QURE Nasdaq
- BGSI Nasdaq
- Market Cap
- QURE 4.3B
- BGSI 4.4B
- IPO Year
- QURE 2007
- BGSI N/A
- Fundamental
- Price
- QURE $30.76
- BGSI $153.51
- Analyst Decision
- QURE Strong Buy
- BGSI
- Analyst Count
- QURE 13
- BGSI 0
- Target Price
- QURE $62.33
- BGSI N/A
- AVG Volume (30 Days)
- QURE 4.6M
- BGSI 62.3K
- Earning Date
- QURE 11-10-2025
- BGSI 11-12-2025
- Dividend Yield
- QURE N/A
- BGSI 0.29%
- EPS Growth
- QURE N/A
- BGSI N/A
- EPS
- QURE N/A
- BGSI 0.74
- Revenue
- QURE $15,751,000.00
- BGSI $3,101,279,000.00
- Revenue This Year
- QURE N/A
- BGSI $3.41
- Revenue Next Year
- QURE $229.18
- BGSI $9.32
- P/E Ratio
- QURE N/A
- BGSI $268.13
- Revenue Growth
- QURE N/A
- BGSI 1.42
- 52 Week Low
- QURE $5.50
- BGSI $136.81
- 52 Week High
- QURE $71.50
- BGSI $177.20
- Technical
- Relative Strength Index (RSI)
- QURE 36.57
- BGSI N/A
- Support Level
- QURE $25.24
- BGSI N/A
- Resistance Level
- QURE $31.16
- BGSI N/A
- Average True Range (ATR)
- QURE 3.74
- BGSI 0.00
- MACD
- QURE -2.28
- BGSI 0.00
- Stochastic Oscillator
- QURE 16.43
- BGSI 0.00
About QURE uniQure N.V.
uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases.
About BGSI Boyd Group Services Inc.
Boyd Group Services Inc is engaged in operating non-franchised collision repair centers in North America. The Company's primary line of business is automotive collision and glass repair and related services, with the majority of revenues relating to this group of similar services. This line of business operates in Canada and the U.S. and both regions exhibit similar long-term economic characteristics. he Company is also a retail auto glass operator in the United States, under the trade names Gerber Collision & Glass, Glass America, Auto Glass Service, Auto Glass Authority, and Autoglassonly.com. In addition, the Company operates a third-party administrator, Gerber National Claims Services (GNCS), that offers glass, emergency roadside, and first notice of loss services.